|
Jun 18
|
High Growth Tech Stocks in Europe for June 2025
|
|
Jun 18
|
High Growth Tech Stocks In Europe To Watch
|
|
Jun 5
|
This IBD 50 Biotech's Got 'Rhythm' — And Flashes 3 Telltale Clues
|
|
Jun 3
|
Nurix Therapeutics (NRIX) Moves 14.2% Higher: Will This Strength Last?
|
|
Jun 3
|
argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
|
|
Apr 28
|
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
|
|
Jan 1
|
Exploring High Growth Tech Stocks for January 2025
|
|
Oct 9
|
argenx SE (ARGNF) Q2 2024 Earnings Call Highlights: Strong Financial Performance Amid ...
|
|
Oct 7
|
Zacks.com featured highlights include Argenx SE Alphatec and Olin
|
|
Jul 31
|
Three Stocks That Could Be Trading Below Fair Value In July 2024
|
|
Jul 30
|
Argenx (ARGX) Upgraded to Buy: Here's What You Should Know
|
|
Jul 25
|
argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update
|
|
Jun 24
|
Argenx Surges After Its Bread-And-Butter Drug Wins Another FDA Approval
|
|
Jun 24
|
FDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder
|
|
Jun 24
|
FDA approves argenx’s VYVGART Hytrulo for CIDP treatment
|
|
Jun 21
|
argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy
|
|
May 10
|
argenx SE (NASDAQ:ARGX) Q1 2024 Earnings Call Transcript
|
|
May 9
|
argenx Reports First Quarter 2024 Financial Results and Provides Business Update
|
|
May 8
|
Is a Surprise Coming for argenx (ARGX) This Earnings Season?
|
|
May 7
|
argenx announces results of Annual General Meeting of Shareholders
|